-
The surge in COVID-19 infections calls for no slack in preparedness
Data from the WHO's sentinel surveillance system spread across 84 countries show that the percentage of people testing positive for the virus has been rising over the past few weeks. Overall, more than 10 percent tested positive. The ratio fluctuates by region. In Europe, the positive rate is more than 20%. The Americas, Europe and the Western Pacific are all seeing new waves of infections.
19-08-2024 -
COVID-19 is making a comeback in several countries
Recently, the positive rate of COVID-19 has been increasing globally, with increases in the Eastern Mediterranean, Europe and the Americas, and decreases in other regions. At present, JN.1, KP.2 and KP.3 are the main circulating strains in the world, and the variant strain LB.1 is listed as a variant strain under surveillance (VUM) by WHO.
09-08-2024 -
Coronavirus, flu and RSV cases surge in California
According to multiple data, the total number of hospital admissions for COVID-19 cases reached 2,088 in the week ending Nov. 25, and more than 19,400 new hospitalizations of mycoplasma pneumoniae, meanwhile the RSV also entered the peak of infection.
20-12-2023 -
World Stroke Day: Focus on prevention
Stroke, also known as cerebrovascular disease, is a sudden occurrence of cerebrovascular circulation disorders, mainly including ischemic stroke and hemorrhagic stroke.
27-10-2023 -
The peak of the second wave of the epidemic is imminent, how to prevent and control the SARS-CoV-2?
Academician Zhong Nanshan said at the Biomedicine and Health sub-forum of the 2023 Greater Bay Area Science Forum that the forecast based on the seirs model shows that the peak of the second wave of the SARS-CoV-2 epidemic in 2023 will occur at the end of June, about 65 million per week.
14-06-2023 -
Wiz Biotech signed a strategic cooperation agreement with Zhuqiang Large Pharmacy on COVID-19 antigen reagents
On the afternoon of December 21, Xiamen Wiz Biotech Co., Ltd. and Xiamen Zhuqiang Large Pharmacy Co., Ltd. had an in-depth discussion on how to meet citizens' demand for novel coronavirus antigen test kits, reached and established a strategic partnership, to assist Xiamen in epidemic prevention and control.
22-12-2022 -
2019-nCoV Antigen Test was approved by CFDA
Recently, the new coronavirus (2019-nCoV) antigen detection kit (Colloidal gold method) developed by Xiamen Wiz Biotech Co., Ltd. has been approved by the National Medical Products Administration.
12-12-2022 -
Wiz Biotech's production line is fully open
In the workshop of Xiamen Wiz Biotech Co., Ltd, workers dressed in neat overalls sit in front of the operating table and methodically pack test reagents for COVID-19 antigen.
12-10-2021 -
Wiz Biotech contributes to global pandemic preparedness
As of September 26, 267 cases of COVID-19 had been confirmed in Xiamen, of which 221 had been confirmed. During the epidemic, the local government has carried out multiple rounds of citywide epidemic screening, establishing a reliable barrier for epidemic prevention and control.
26-09-2021 -
The export of novel coronavirus reagents has been approved, marking the start of the global fight against COVID-19
COVID-19 has become a "global epidemic", and all countries are in urgent need of COVID-19 testing reagents. In order to effectively support the international community in tackling the global epidemic crisis,
28-04-2020